SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Macrotroponin-Analytical Anomaly or Clinical Confounder.

Collinson, P (2022) Macrotroponin-Analytical Anomaly or Clinical Confounder. Clin Chem, 68 (10). pp. 1229-1231. ISSN 1530-8561 https://doi.org/10.1093/clinchem/hvac129
SGUL Authors: Collinson, Paul

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (51kB)
Item Type: Article
Additional Information: This is a pre-copyedited, author-produced version of an article accepted for publication in Clinical Chemistry following peer review. The version of record Paul Collinson, Macrotroponin—Analytical Anomaly or Clinical Confounder, Clinical Chemistry, Volume 68, Issue 10, October 2022, Pages 1229–1231 is available online at: https://doi.org/10.1093/clinchem/hvac129
Keywords: 1004 Medical Biotechnology, 1101 Medical Biochemistry and Metabolomics, 1103 Clinical Sciences, General Clinical Medicine
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Clin Chem
ISSN: 1530-8561
Language: eng
Dates:
DateEvent
October 2022Published
5 August 2022Published Online
11 July 2022Accepted
Publisher License: Publisher's own licence
PubMed ID: 35929570
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114716
Publisher's version: https://doi.org/10.1093/clinchem/hvac129

Statistics

Item downloaded times since 25 Aug 2022.

Actions (login required)

Edit Item Edit Item